Cargando…
Elf5 - breast cancer's little helper
A variety of transcription factors has been shown to regulate lineage commitment in the mammary gland and to be associated with different molecular subtypes of breast cancer. E74-like factor 5 (Elf5) has now been identified as a marker of oestrogen receptor status, and high expression correlates wit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672774/ https://www.ncbi.nlm.nih.gov/pubmed/23534926 http://dx.doi.org/10.1186/bcr3397 |
_version_ | 1782272173502627840 |
---|---|
author | Frend, Hayley T Watson, Christine J |
author_facet | Frend, Hayley T Watson, Christine J |
author_sort | Frend, Hayley T |
collection | PubMed |
description | A variety of transcription factors has been shown to regulate lineage commitment in the mammary gland and to be associated with different molecular subtypes of breast cancer. E74-like factor 5 (Elf5) has now been identified as a marker of oestrogen receptor status, and high expression correlates with more aggressive basal cancers and resistance to anti-oestrogens. Manipulation of Elf5 transcript levels perturbs the molecular profiles of luminal and basal subtypes, highlighting the possibility that targeting Elf5 could provide a new approach for the treatment of basal cancers. |
format | Online Article Text |
id | pubmed-3672774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36727742013-09-27 Elf5 - breast cancer's little helper Frend, Hayley T Watson, Christine J Breast Cancer Res Viewpoint A variety of transcription factors has been shown to regulate lineage commitment in the mammary gland and to be associated with different molecular subtypes of breast cancer. E74-like factor 5 (Elf5) has now been identified as a marker of oestrogen receptor status, and high expression correlates with more aggressive basal cancers and resistance to anti-oestrogens. Manipulation of Elf5 transcript levels perturbs the molecular profiles of luminal and basal subtypes, highlighting the possibility that targeting Elf5 could provide a new approach for the treatment of basal cancers. BioMed Central 2013 2013-03-27 /pmc/articles/PMC3672774/ /pubmed/23534926 http://dx.doi.org/10.1186/bcr3397 Text en Copyright © 2013 BioMed Central Ltd |
spellingShingle | Viewpoint Frend, Hayley T Watson, Christine J Elf5 - breast cancer's little helper |
title | Elf5 - breast cancer's little helper |
title_full | Elf5 - breast cancer's little helper |
title_fullStr | Elf5 - breast cancer's little helper |
title_full_unstemmed | Elf5 - breast cancer's little helper |
title_short | Elf5 - breast cancer's little helper |
title_sort | elf5 - breast cancer's little helper |
topic | Viewpoint |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672774/ https://www.ncbi.nlm.nih.gov/pubmed/23534926 http://dx.doi.org/10.1186/bcr3397 |
work_keys_str_mv | AT frendhayleyt elf5breastcancerslittlehelper AT watsonchristinej elf5breastcancerslittlehelper |